The genes of the human ,B locus are arranged 5' e, G9, A , 8, 1 3' and display two developmental switches, from embryonic (e) to fetal (Gy and Ay) during early fetal development and from fetal to adult (5 and 13) during the perinatal period. The genes of the 13 locus are regulated by the locus control region (LCR), which contains a series of erythroid cell-specific and developmentally stable DNase I hypersensitive sites located 6 to 20 kb upstream of the e-globin gene (18, 27, 41) . The region is responsible for activating the 1 locus domain (17) and facilitating high-level globin gene transcription in erythroid cells (27) . Deletions of the LCR result in inactivation of the ,B-globin locus and the phenotype of ,B-thalassemia (10, 12, 16, 31) . Linkage to the LCR results in high-level expression of globin genes or heterologous genes in erythroid cells of transgenic mice; 1-globin expression is copy number dependent and independent of the site of integration of the transgene (27) . The LCR thus appears to play a role in stabilization of open chromatin (15, 17, 27) . It has been proposed that the primary role of the LCR is to enter into cooperative binding interactions that keep the promoter free of histones (15) .
The developmental control of human -y-globin genes has been investigated with transgenic mice. Initially, y gene regulation was analyzed by using y gene constructs lacking LCR sequences; these transgenes are expressed in the embryonic cells of the yolk sac but not in the definitive cells of the fetal liver or the bone marrow erythropoiesis, suggesting that the y genes contain the cis sequences which are al. (13) linked a 3.3-kb A-y gene fragment (previously shown to be developmentally regulated in transgenic mice [32] ) to a LCR cassette and found that ry gene expression was not limited to the cells of the embryonic erythropoiesis but that it continued in the fetal and the adult stages of development, suggesting that the LCR overrides the developmental control of -y genes. A similar conclusion was reached by Behringer et al. (2) , who linked a 22-kb fragment of the LCR to the A_Y gene and determined y gene expression in the yolk sac cells, in the liver cells of 16-day fetuses, and in adult erythrocytes. In the studies of both Enver et al. (13, 14) and Behringer et al. (2) , y gene expression in the adult was about one-third to one-fifth of that in the embryo or in the fetus. Dillon and Grosveld (11) , however, observed correct developmental regulation of the A-Y genes of micro-LCR or mini-LCR constructs and suggested that the y genes are switched off autonomously, through silencing.
In the experiments we describe here, we produced transgenic lines carrying various -y gene promoter truncations and analyzed -y gene expression in embryonic, fetal, and adult erythrocytes. We find that a A-Y gene construct with a promoter containing the TATA box and the duplicated CAAT box is regulated correctly, i.e., it is expressed in embryonic and fetal cells but only minimally in the adult cells. Downregulation of the y gene in the adult stage is totally abolished when 60 bp of sequence (-141 to -201 HPFH: a -175 T-to-C substitution in Black Gy (38) , in Black A.y (39) , and in Sardinian A.y (34) HPFH mutants; a -195 C-to-G substitution in Brazilian HPFH (8); a -196 C-to-T substitution in Italian (23) and Chinese (21) HPFH; and a -198 T-to-C substitution in British HPFH (40) . A polymorphism in position -158 has been associated with increased efficiency of -y-globin production in patients with sickle cell disease and homozygous ,-thalassemia (24) .
Seven of the founders produced by using the ,LCR -201 -y construct contained correctly integrated transgenes and were used for our studies. All adult animals showed high -y gene expression (from 8.6 to 20.5% of murine a [ Table 2 ]).
Mean -y gene expression (13.6% of murine a) was 36-fold higher than in the adult animals carrying the ,uLCR -141 A.Y construct.
Developmental studies, done with three lines, essentially showed no change in the level of Ay gene expression during development ( Fig. 3 ; Table 2 ). The ratio of -y expression in the fetus over y expression in the adult was 1.24 in line E, 1.26 in line F, and 1.27 in line G ( Ay genes is the site of two HPFH mutations at position -202: a C-to-G substitution in c0y HPFH (7) and a C-to-T substitution in A-y HPFH (25) . Extension of the A-y promoter to the -382 StuI site provided results identical to those of the ,uLCR -201 A.y transgene. Seven founders with correctly integrated transgenes were used for our analyses. -y expression in the adult ranged from 8.4 to 19.7% of murine ao ( Fig. 3; Table 3 ). The mean -y expression in the adult (14.6%) was similar to that of the ,uLCR -201 A) transgenic mice (13.6%).
Developmental studies showed minimal decline or no decline in -y expression between the fetal and adult stages of development ( Fig. 3; Table 3 ). The y fetus/-y adult ratio was Ay construct was the lack of correlation between copy numbers of the transgene and the level of -y gene expression in the adult animals ( Fig. 5 ) or in fetuses. There was a 480-fold difference in y gene expression (per copy) between the highest (founder 137 1-5) and the lowest (line K) levels of expression among the adult animals. In the fetuses, there was a 10-fold difference in expression between the lines showing the highest (line P, 38.8% -y in the 13-day fetuses) and the lowest (Line N, 3.7% -y in the 10-day embryo)
values.
Among the adult animals of five lines which carried two copies of the transgene (lines K, L, N, 0, and P), -y gene expression differed 170-fold; among fetuses of the same lines, -y gene expression differed 10-fold (Table 4) .
Regression analysis showed a lack of correlation between the level of -y gene expression and the number of copies of the transgene (r = 0.38; P > 0.1). These results indicate that the addition of the sequence between -382 Ay and -730 A_ makes -y gene expression sensitive to effects related to the position of integration of the transgene.
'y gene downregulation decreases the frequency of 'y-globinpositive erythrocytes. Staining with fluorescent anti--y-globin chain antibodies was used to assess the cellular distribution of -y-globin in the erythrocytes of the adult mice (Fig. 6) Fig. 6C and D) . These results suggest that the outcome -400 and -1350 of the A-y promoter was previously inferred from studies of K562 cells transfected with constructs containing -y gene promoter truncations linked to the LCR (3). (19, 27) , constructs containing -y genes linked to LCR sequences usually display copy-number-independent expression of the -y transgenes.
Thus, there is about a 10-fold difference in y gene expression between two lines produced using a ,uLCR A_ construct in which the 5' end of Ay gene extends to -1350 and the 3' end extends to +1950 (13, 14 , and unpublished data). Dillon and Grosveld produced transgenic animals by using a construct linking LCR cassettes to an Ay gene, the 5' of which extends to -1350 and the 3' end of which extends to +4540. Because of position effects on -y gene expression, Dillon and Grosveld presented, in their paper showing complete -y gene regulation, only results from animals containing one or two copies of the y transgene (11) . Copy-number-independent expression of -y gene can also be calculated from the results published by Lloyd et al. (33) ; the 5' end of the two constructs used by these authors was at -1350 Ay, while the 3' end of one construct was similar to that used by Enver et al. (13) and the 3' end of the second construct extended to +2700. Overall, our results and results from the literature indicate that y gene constructs containing the -382 to -730 sequence are sensitive to modulation of expression by the surrounding chromatin. The differences in -y gene expression which are characteristic of the 813-thalassemia and HPFH deletion mutants (in which the -y genes are found in different positions vis-a-vis the downstream chromatin) may have a similar origin.
Our results suggest that multiple elements participate in -y gene silencing. The negative element(s) 3' to -141 may represent the site of binding of repressors of -y gene transcription (Fig. 7) . The upstream negative regulatory element residing between -730 and -382 of the -y gene promoter may not be a silencer in the classical sense. This element may downregulate -y gene expression by disrupting the interaction between -y gene promoter and the LCR in the adult stage of development (Fig. 7) . These two elements may be necessary but not sufficient for complete silencing of -y gene expression in the adult. Complete silencing may require the contribution of the third element, i.e., the 1 gene which competes with the -y gene, in the adult stage of development, for interaction with the LCR (2, 14) . We would also like to suggest that the combined action of all three elements is required for complete -y gene silencing, and that disruption of a single element results in continuation of -y-globin expression in the adult. This can explain why HPFH phenotypes can be produced either by mutations of the minimal promoter or by mutations of the upstream promoter or by 8 and ,B gene deletions (37) . The HPFH mutants affecting the distal CAAT box of the -y gene may disrupt the function of the element acting on minimal promoter, the HPFH mutants affecting the upstream promoter (-175 to -202 region) may inhibit the function of the -382 to -730 silencer, and the HPFH and 8,B-thalassemia mutants due to deletions of the 8 and 13 may genes represent the outcome of the lack of 13 gene competition.
